Status:
COMPLETED
Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Anxiety Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a clinical trial assessing duloxetine compared with placebo in patients who have generalized anxiety disorder.
Eligibility Criteria
Inclusion
- Male and female outpatients at least 18 years of age
Exclusion
- Have previously completed or withdrawn from this study or any other study investigating duloxetine or have previously been treated with duloxetine
- Patient diagnosed with major depressive disorder within the past 6 months
- Patient diagnosed with panic disorder, post-traumatic stress disorder, or an eating disorder within the past year
- History of alcohol or any psychoactive substance abuse or dependence within the past 6 months
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00122824
Start Date
June 1 2004
End Date
September 1 2005
Last Update
November 6 2007
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Cincinnati, Ohio, United States, 45242
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Oulu, Finland, 90100
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Bourg-en-Bresse, France, 01000
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Berlin, Germany, 10629